MAB9012
抗-冠状病毒抗体，OC-43菌株，克隆541-8F
clone 541-8F, Chemicon®, from mouse
登录 查看组织和合同定价。
选择尺寸
关于此项目
UNSPSC Code:
12352203
NACRES:
NA.41
eCl@ss:
32160702
Clone:
541-8F, monoclonal
Species reactivity:
human
Application:
immunofluorescence
Technique(s):
immunofluorescence: suitable
Citations:
37
产品名称
抗-冠状病毒抗体，OC-43菌株，克隆541-8F, clone 541-8F, Chemicon®, from mouse
biological source
mouse
antibody form
purified immunoglobulin
antibody product type
primary antibodies
clone
541-8F, monoclonal
species reactivity
human
manufacturer/tradename
Chemicon®
technique(s)
immunofluorescence: suitable
shipped in
wet ice
Quality Level
Application
IFA。 最终工作稀释度必须由最终用户确定。
抗冠状病毒抗体，OC-43株，克隆541-8F可检测冠状病毒水平，&已发布&验证可用于IF。
研究子类别
传染病 - 病毒
传染病 - 病毒
研究类别
传染病
传染病
Biochem/physiol Actions
冠状病毒。
Disclaimer
除非我们的目录或产品随附的其他公司文件中另有说明，否则我们的产品预期仅用于研究用途，不得用于任何其他目的，包括但不限于未经授权的商业用途、体外诊断用途、离体或体内治疗用途或对人类或动物的任何类型的消费或应用。
Immunogen
表位：OC-43株
Physical form
形式：纯化
纯化的免疫球蛋白。提供在pH 7.4的PBS缓冲液中。含0.1%叠氮化钠和载体蛋白。
Preparation Note
自接收之日起，在2-8°C下保存长达6个月。
Legal Information
CHEMICON is a registered trademark of Merck KGaA, Darmstadt, Germany
未找到合适的产品？
试试我们的产品选型工具.
存储类别
10 - Combustible liquids
wgk
WGK 2
flash_point_f
Not applicable
flash_point_c
Not applicable
Layla Pires et al.
Scientific reports, 12(1), 14438-14438 (2022-08-25)
The lack of therapeutic options to fight Covid-19 has contributed to the current global pandemic. Despite the emergence of effective vaccines, development of broad-spectrum antiviral treatment remains a significant challenge, in which antimicrobial photodynamic therapy (aPDT) may play a role
Kai-Wen Cheng et al.
Cells, 10(11) (2021-11-28)
Human coronavirus (HCoV) similar to other viruses rely on host cell machinery for both replication and to spread. The p97/VCP ATPase is associated with diverse pathways that may favor HCoV replication. In this study, we assessed the role of p97
Yanmei Hu et al.
Journal of medical virology, 94(5), 2188-2200 (2022-01-27)
Brilacidin, a mimetic of host defense peptides (HDPs), is currently in Phase 2 clinical trial as an antibiotic drug candidate. A recent study reported that brilacidin has antiviral activity against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) by inactivating the
Peifang Xie et al.
Phytomedicine : international journal of phytotherapy and phytopharmacology, 93, 153808-153808 (2021-11-10)
Qingwenjiere Mixture (QJM) is a traditional Chinese medicine (TCM) that has been shown to have remarkable clinical efficacy against COVID-19. However, little is known about the antiviral and anti-inflammatory activities of QJM against a wider range of human coronavirus (HCoV)
Peifang Xie et al.
Frontiers in microbiology, 13, 845269-845269 (2022-06-28)
The human coronavirus OC43 (HCoV-OC43) is one of the most common causes of common cold but can lead to fatal pneumonia in children and elderly. However, the available animal models of HCoV-OC43 did not show respiratory symptoms that are insufficient
我们的科学家团队拥有各种研究领域经验，包括生命科学、材料科学、化学合成、色谱、分析及许多其他领域.
联系客户支持